
Analysis of economic impact among modalities of renal replacement therapy
2017; Sociedade Brasileira de Nefrologia; Volume: 39; Issue: 2 Linguagem: Inglês
10.5935/0101-2800.20170019
ISSN2175-8239
AutoresDenise Sbrissia e Silva Gouveia, Alexandre Tortoza Bignelli, Sílvia Regina Hokazono, Itamara Pereira Danucalov, Tobias August Siemens, Fernando Meyer, Luiz Sérgio Santos, Ziliane Caetano Lopes Martins, Tiago César Mierzwa, Raquel Furquim,
Tópico(s)Business Strategy and Innovation
ResumoIntroduction: Chronic kidney disease (CKD) is a major health problem, determining the reduction in life expectancy and an increased risk of cardiovascular disease. Method: An observational, cohort, retrospective, based on patient's medical records data with CKD under hemodialysis, peritoneal dialysis and kidney transplantation in the city of Curitiba, in the period from January to June 2014, evacuativo the financial impact on the Unified Health System (SUS) and the supplementary health. Results: The lowest cost of a kidney transplant in the first year was R$ 40,743.03 when cyclosporine was used and the highest was R$ 48,388.17 with the use of tacrolimus. In the second year post-transplant, hemodialysis and peritoneal dialysis have a higher cost compared to kidney transplant. Transplantation with deceased donor, treated with tacrolimus: R$ 67,023.39; Hemodialysis R$ 71,717.51 and automated peritoneal dialysis automatic R$ 69,527.03. Conclusions: After the first two years of renal replacement therapy, transplantation demonstrates lower costs to the system when compared to other modalities evaluated. Based on that, this therapy justifies improvements in government policies in this sector.
Referência(s)